Back to Companies Directory
VERIFIED COMPANY DOSSIER
Nightstar Therapeutics plc (NASDAQ: NITE) is a leading clinical-stage gene therapy company focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases including choroideremia, X-linked retinitis pigmentosa and Best vitelliform macular dystrophy.
Primary SectorBiotechnology
Workforce Size11-50 Employees
Global HQLondon, Global
Total Capital Raised$174,592,828
Corporate Firmographics
Entity classification and operating profile
- Industry
- Biotechnology
- Company Type
- Public Company
- Founded
- 2013
- Employee Bracket
- 11-50
- Estimated Revenue Range
- $5,000,000 – $10,000,000
Geographic Coordinates
Headquarters address and regional territory
- Street Address
- Corporate address undisclosed
- City
- London
- Region / State
- england
- Postal Code
- —
- Country
- Global
Core Competencies & Specialties
Synthesized domain expertise tags
Gene TherapyOphthalmologyRetinal DiseasesBiotechnologyChoroideremiaRetinitis PigmentosaBest Vitelliform Macular DystrophyStargardt Disease
Digital Presence & Footprint
Verified domains, socials, and directory profiles
LinkedIn Network2,555 Followers
Open LinkedInCrunchbaseVenture Dossier
Inspect CrunchbaseSYNTHESIZED INTEL
Frequently Asked Questions
Verified business inquiries and firmographic telemetry for NIGHTSTAR THERAPEUTICS.